Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
Treatment of Retinopathy of Prematurity with Biosimilar Ranibizumab Seems Effective.
Read Full NewsThe 1-hour troponin pathway was safely implemented in a real-world study but did not impact workflow in busy emergency departments.
Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.
A multicenter phase 3 trial has associated a cardiac myosin inhibitor with meaningful clinical benefit in nonobstructive HCM, for which there has been no effective therapies.
Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.
1.
CD39 Blockade Shows Potential in Early-Stage Lung Cancer
2.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
3.
Surgeons are at higher risk of cancer, study suggests
4.
Recent Rise in Early-Onset Solid Tumors Is Associated with Accelerated Aging.
5.
Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL
1.
Uncovering New Hope for Follicular Lymphoma Patients
2.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
3.
Clinical Trends in Oncology in Clinical Decision-Making
4.
Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management
5.
A New Hope: Exploring the Potential of Pegaspargase in Treating Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
2.
Navigating the Complexities of Ph Negative ALL - Part VII
3.
Updates on Standard V/S High Risk Myeloma Treatment
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge